dual myasthenogenic peptide analog (Weizmann)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual myasthenogenic peptide analog (Weizmann)
Drug Alias NameLys-262-Ala-207
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokines modulators
TargetsCytokines
Therapy Area/IndicationsMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMyasthenia Gravis

Other Information

ATC CodeN/A
Related LinksN/A